Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00625638 · ClinicalTrials.gov registry record · NA

Interactive Voice Response System in Advanced Cancer Patients

A NA study of Advanced Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT00625638 is a NA study of Advanced Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 136 participants, below the 245-participant average among 122 other Advanced Cancer trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00625638, a NA study of Advanced Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to learn if using an Interactive Voice Response (IVR) system can bring about better and more timely symptom control for patients with advanced cancer. Primary Objectives: * To determine whether the Interactive Voice Response (IVR) system, supplemented by Nursing Telephone Intervention (NTI), results in better symptom management and quality of life than standard care for individuals with advanced cancer as evidenced by reduced scores on symptom measures. * To determine whether the IVR system, supplemented by NTI, results in reduced caregiver burden, increased caregiver satisfaction with care, and improved coping strategies. * To determine the feasibility of using an IVR system, supplemented by NTI, for symptom assessment in individuals with advanced cancer and their caregivers by conducting a process evaluation of the system. Variables to be evaluated include rates of participant recruitment and retention, frequency of use of the system, acceptability of the system to participants, and barriers to participation. Researchers' goal is to identify and improve aspects that affect external validity (recruitment rate, cohort maintenance), internal validity (implementation, contamination), participant acceptability and satisfaction, and reaction to study procedures. The findings from this evaluation will also allow researchers to evaluate delivery of interventions in future studies.

Conditions Studied

Interventions

  • OTHER Standard Care
  • BEHAVIORAL Interactive Voice Response System

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2008-01-28
Est. Completion 2022-12-02
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00625638

The ClinicalTrials.gov registry entry for NCT00625638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 122 other Advanced Cancer trials with a reported enrollment target (44% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.

NCT00625638 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00625638 about?

NCT00625638 is a clinical study titled "Interactive Voice Response System in Advanced Cancer Patients". The goal of this research study is to learn if using an Interactive Voice Response (IVR) system can bring about better and more timely symptom control for patients with advanced cancer. Primary Objectives: * To determine whether the Interactive Voice Response (IVR) system, supplemented by Nursing ...

What is the current status of trial NCT00625638?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2008-01-28. Estimated completion is 2022-12-02.

What conditions does trial NCT00625638 study?

This clinical trial studies the following conditions: Advanced Cancer.

What interventions are being tested in trial NCT00625638?

The interventions under investigation include: Standard Care (OTHER), Interactive Voice Response System (BEHAVIORAL).

Who is sponsoring clinical trial NCT00625638?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00625638 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.